De Novo
DEN110001: RIDASCREEN NOROVIRUS 3RD GENERATION EIA
FDA De Novo · r-biopharm ag · decided Feb 23, 2011
Key facts
| De Novo number | DEN110001 |
|---|---|
| Device name | RIDASCREEN NOROVIRUS 3RD GENERATION EIA |
| Applicant | r-biopharm ag |
| Product code | OUC |
| Date received | Feb 16, 2011 |
| Decision date | Feb 23, 2011 |
| Decision | granted (DENG) |
| FDA classification | Class II |
| Review panel | Microbiology |
| FEI number | 3004061467 |
At a glance
- None Later 510(k)s citing this De Novo
- 1–9 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: